[Federal Register Volume 63, Number 66 (Tuesday, April 7, 1998)]
[Notices]
[Page 17017]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-8598]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Agency Information Collection Activities: Extension of a
Currently Approved Collection; Comment Request
ACTION: Application for individual manufacturing quota for a basic
class of controlled substance.
-----------------------------------------------------------------------
The information collection is published to obtained comments from
the public and affected agencies. Comments are encouraged and will be
accepted until June 8, 1998.
We are requesting written comments and suggestions from the public
and affected agencies concerning the collection of information. Your
comments should address one or more of the following four points:
1. Evaluate whether the collection of information is necessary for
the proper performance of the functions of the agency, including
whether the information will have practical utility;
2. Evaluate the accuracy of the agencies estimate of the burden of
the collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected; and
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submission of responses.
Comments and/or suggestions regarding the item(s) contained in this
notice, especially regarding the estimated public burden and associated
response time should be directed to Mr. Frank Sapienza, 202-307-7183,
Chief, Drug and Chemical Evaluation Section, Office of Diversion
Control, Drug Enforcement Administration, Washington, DC 20537. If you
have additional comments, suggestions, or need a copy of the
information collection instrument with instructions, or additional
information, please contact Mr. Frank Sapienza.
Additionally, comments may also be submitted to the Department of
Justice (DOJ), Justice Management Division, Information Management and
Security Staff, Attention: Department Clearance Officer, Suite 850,
Washington Center, 1001 G Street, NW, Washington, DC 20530. Additional
comments may be submitted to DOJ via facsimile at 202-514-1590.
Overview of this information collection:
1. Type of Information Collection: Extension of a currently
approved collection.
2. Title of the Form/Collection: Application for Individual
Manufacturing Quota for A Basic Class of Controlled Substance.
3. Agency form number: DEA Form 189; Applicable component of the
Department of Justice sponsoring the collection: Office of Diversion
Control, Drug Enforcement Administration, Department of Justice.
4. Affected public who will be asked or required to respond, as
well as a brief abstract: Primary: Business or other for-profit. Other:
None.
Title 21, CFR, 1303.22 requires that any person who is registered
to manufacture any basic class of controlled substance listed in
Schedule I or II and who desires to manufacture a quantity of such
class shall apply on DEA Form 189 for a manufacturing quota for such
quantity of such class.
5. An estimate of the total estimated number of respondents and the
amount of time estimated for an average respondent to respond: 27
respondents at approximately 10 responses per year at .5 hour per
response.
6. An estimate of the total public burden (in hours) associated
with the collection: 135 annual burden hours.
Public comment on this proposed information collection is strongly
encouraged.
Dated: March 27, 1998.
Robert B. Briggs,
Department Clearance Officer, United States Department of Justice.
[FR Doc. 98-8598 Filed 4-6-98; 8:45 am]
BILLING CODE 4410-09-M
